SAB Biotherapeutics Inc. (SABS)
1.56
-0.15 (-8.77%)
At close: Mar 03, 2025, 3:59 PM
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $2.24M, reflecting a -90.63% growth. For the quarter ending September 30, 2024, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
$2.24M
Revenue Growth
-90.63%
Price / Sales Ratio
16.97
Revenue / Employee
$39.28K
Employees
57
Market Cap
14.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 2.24M | -90.63% |
| Dec 31, 2022 | 23.9M | -60.73% |
| Dec 31, 2021 | 60.88M | +10.21% |
| Dec 31, 2020 | 55.24M | n/a |